Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$628M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$608M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 4 |
Intel
INTC
|
+$172M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 2 |
Amazon
AMZN
|
+$437M |
| 3 |
Microsoft
MSFT
|
+$405M |
| 4 |
NVIDIA
NVDA
|
+$226M |
| 5 |
LyondellBasell Industries
LYB
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.07% |
| 2 | Financials | 5.69% |
| 3 | Healthcare | 5.49% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
2026
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.17M | ﹤0.01% |
164,559
+94,099
| +134% | +$1.04M |
|
2027
iShares Short Maturity Bond ETF
NEAR
$4.82B
| $2.16M | ﹤0.01% |
43,795
-163
| -0.4% | -$8.06K |
|
2028
Sabre
SABR
$716M
| $2.15M | ﹤0.01% |
368,723
+146,797
| +66% | +$1.23M |
|
2029
Cogent Communications
CCOI
$635M
| $2.14M | ﹤0.01% |
35,300
-15,989
| -31% | -$984K |
|
|
ROIC
2030
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.14M | ﹤0.01% |
135,791
-68,569
| -34% | -$1.22M |
|
2031
Applied Industrial Technologies
AIT
$12.4B
| $2.14M | ﹤0.01% |
22,265
-16,652
| -43% | -$1.68M |
|
2032
Revolution Medicines
RVMD
$38.5B
| $2.13M | ﹤0.01% |
109,547
+80,987
| +284% | +$1.58M |
|
2033
Heron Therapeutics
HRTX
$93.4M
| $2.13M | ﹤0.01% |
763,515
+612,908
| +407% | +$2.46M |
|
2034
CALL
TG Therapeutics
TGTX
$8.19B
| $2.13M | ﹤0.01% |
+500,000
| New | +$3.12M |
|
|
VPCB
2035
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
| $2.13M | ﹤0.01% |
216,870
| – | – |
|
2036
FirstService
FSV
$6.55B
| $2.12M | ﹤0.01% |
17,548
+14,825
| +544% | +$1.87M |
|
2037
CALL
Fortinet
FTNT
$112B
| $2.12M | ﹤0.01% |
37,500
| – | – |
|
2038
Fluor
FLR
$6.54B
| $2.12M | ﹤0.01% |
87,116
-9,158
| -10% | -$246K |
|
2039
Karyopharm Therapeutics
KPTI
$155M
| $2.12M | ﹤0.01% |
31,268
+22,749
| +267% | +$2.09M |
|
2040
CALL
Zoom
ZM
$27.1B
| $2.1M | ﹤0.01% |
19,500
-110,000
| -85% | -$11.6M |
|
2041
KB Financial Group
KB
$39.5B
| $2.1M | ﹤0.01% |
56,563
-2,354
| -4% | -$107K |
|
2042
Workiva
WK
$3.45B
| $2.1M | ﹤0.01% |
31,884
-7,371
| -19% | -$614K |
|
2043
Evertec
EVTC
$1.97B
| $2.1M | ﹤0.01% |
56,850
-17,764
| -24% | -$679K |
|
2044
Flex
FLEX
$37.7B
| $2.1M | ﹤0.01% |
192,231
-62,163
| -24% | -$770K |
|
|
ACLX
2045
DELISTED
Arcellx
ACLX
| $2.1M | ﹤0.01% |
115,891
+114,037
| +6,151% | +$1.47M |
|
|
P
2046
Everpure Inc
P
$23B
| $2.09M | ﹤0.01% |
81,411
-60,522
| -43% | -$1.67M |
|
2047
Wintrust Financial
WTFC
$10.7B
| $2.09M | ﹤0.01% |
26,041
+5,924
| +29% | +$510K |
|
2048
Affiliated Managers Group
AMG
$9.51B
| $2.09M | ﹤0.01% |
17,908
-3,458
| -16% | -$445K |
|
|
CERE
2049
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $2.08M | ﹤0.01% |
78,863
+58,159
| +281% | +$1.65M |
|
2050
Essential Properties Realty Trust
EPRT
$6.92B
| $2.08M | ﹤0.01% |
96,861
-54,014
| -36% | -$1.26M |
|
Similar funds
Citigroup's Q2 2022 Portfolio in Review
As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
- Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
- Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
- Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
- Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
- Citigroup opened 507 new positions and closed 579 in Q2 2022.
- Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.